Canadian supplier Advitech has announced it is taking its psoriasis
product Dermylex to France and Belgium through a distribution
agreement with a pharmaceutical corporation, Iprad Santé S.A.
Jamieson Laboratories, a leading manufacturer of natural health
products in Canada, has upped distribution of Advitech's psoriasis
nutraceutical Dermylex from six pharmacies to 2000 across the
country since November, and is eyeing...
Advitech, the maker of psoriasis nutraceutical Dermylex, has
announced the signing of a definitive agreement with Enbio-Life
Biotech and Medical Company for distribution in Taiwan - the latest
development in the oral supplement's...
Advitech, the maker of psoriasis nutraceutical Dermylex, signed on
a former Canadian Olympian to promote the product in order to build
a testimonial base and draw the over one third of psoriasis
patients it said are outside the traditional...
Advitech, the maker of psoriasis nutraceutical Dermylex has
announced it is signing on a former Canadian Olympian to promote
its whey-derived ingredient - this is the latest in a series of
announcements as the company plugs the oral...
Advitech announced its first significant sales of psoriasis
supplement Dermylex have propped-up financial results for its third
quarter ended September 30, 2006.
Advitech's global roll out plan for its psoriasis nutraceutical
Dermylex is coming together, with definitive agreements in Canada
and France, interim financing, and new appointments as it moves
into the implementation phase.
Advitech is embroiled in discussions with potential partners to
bring its XP-828L product to market, targeting sufferers of mild to
moderate psoriasis and other inflammatory diseases.
Canada's Advitech is continuing with the clinical trial program for
XP-828L sweet whey protein extract to give the product weight with
dermatologists and help it achieve its market potential - an effort
which led the biotech...
